What is Grade I cholecystitis characterized by a distended gallbladder with phlegmon or hydrops, necrosis or gangrene of the wall, iatrogenic perforation, chronic active cholecystitis, and focal cholesterolosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Grade I Cholecystitis: Characteristics and Management

Grade I cholecystitis is characterized by a distended gallbladder with inflammation (phlegmon or hydrops) that may include wall necrosis or gangrene, iatrogenic perforation, chronic active inflammation, and focal cholesterolosis, representing the mildest form of acute cholecystitis requiring prompt surgical intervention to prevent progression to more severe complications.

Pathological Features of Grade I Cholecystitis

Grade I cholecystitis presents with several key pathological features:

  • Distended gallbladder: Enlarged gallbladder with transverse diameter often exceeding 5cm 1
  • Phlegmon or hydrops: Inflammatory changes in surrounding tissues or fluid accumulation within the gallbladder
  • Wall necrosis or gangrene: Areas of tissue death in the gallbladder wall due to compromised blood supply
  • Iatrogenic perforation: Perforation of the gallbladder wall that occurs during medical procedures
  • Chronic active cholecystitis: Ongoing inflammatory process with both acute and chronic features
  • Focal cholesterolosis: Accumulation of cholesterol deposits in the gallbladder wall

Diagnostic Imaging Findings

Ultrasound (First-Line Imaging)

  • Thickened gallbladder wall (>3mm) 1
  • Pericholecystic fluid or stranding 2
  • Distended gallbladder (>5cm transverse diameter) 1
  • Sonographic Murphy's sign (localized tenderness over the gallbladder) 2
  • In cases with necrosis or gangrene: intraluminal debris, membranes, or hyperechoic blood products 2
  • In cases with perforation: discontinuity of gallbladder wall 2

CT Imaging (For Equivocal Cases)

  • Gallbladder wall thickening
  • Pericholecystic inflammation
  • Adjacent liver parenchymal hyperemia (early finding in acute cholecystitis) 2, 1
  • Gas in gallbladder wall (emphysematous cholecystitis)
  • Pericholecystic fluid collections 2

HIDA Scan (Gold Standard)

  • Non-visualization of the gallbladder even after morphine administration indicates cystic duct obstruction 1, 3
  • Sensitivity of 86.7-89.3% and specificity of 66.8-79% for acute cholecystitis 1

Clinical Significance and Management

Surgical Approach

  • Early laparoscopic cholecystectomy (within 7-10 days of symptom onset) is the preferred treatment 2, 1
  • Delaying surgery beyond 10 days increases risk of complications 1
  • Open cholecystectomy may be necessary in certain cases, particularly with risk factors such as:
    • Age >65 years
    • Male gender
    • Thickened gallbladder wall
    • Diabetes mellitus
    • Previous upper abdominal surgery 2

Initial Management

  • NPO status
  • IV fluid resuscitation
  • Electrolyte correction
  • Pain control
  • Antibiotic therapy 1

Antibiotic Recommendations

  • For non-critically ill patients: Amoxicillin/Clavulanate 2g/0.2g q8h or Eravacycline 1 mg/kg q12h 1
  • For critically ill patients: Piperacillin/tazobactam or Eravacycline 1

Alternative Management for High-Risk Patients

  • Percutaneous cholecystostomy may be considered for patients unfit for surgery 2, 1
  • However, this approach is associated with higher rates of postprocedural complications (65%) compared to laparoscopic cholecystectomy (12%) 3

Potential Complications and Pitfalls

  • Perforation risk: Gallbladder perforation occurs in 2-11% of acute cholecystitis cases with mortality as high as 12-16% 2

  • Types of perforation:

    • Type I: Free perforation with generalized peritonitis
    • Type II: Pericholecystic abscess with localized peritonitis
    • Type III: Cholecysto-enteric fistula 2
  • Diagnostic challenges: Perforation is rarely diagnosed pre-operatively, and delayed intervention increases morbidity, mortality, ICU admission rates, and hospital stay 2

  • Risk factors for severe complications: Older age and elevated white blood cell count are associated with higher risk of gangrene, perforation, or abscess formation 4

Important Considerations

  • Early surgical consultation is essential even with equivocal physical findings 1
  • Patients with ongoing signs of infection beyond 7 days of antibiotic treatment warrant further investigation 1
  • Diabetic patients may present with minimal symptoms despite severe pathology, including gangrenous or perforated cholecystitis 5
  • Prompt intervention is crucial to prevent life-threatening complications such as cholangitis, pancreatitis, or gallbladder perforation 1

References

Guideline

Diagnosis and Management of Acute Cholecystitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.